Discover
VIGL
Vigil Neuroscience, Inc.
8.05
undefined x undefined
undefined x undefined
bid
ask
+
0.00
0.00%
04:00 PM
| Ytd | ||
| 1y |
8.05
day range
8.05
1.54
52 week range
6.06
| Open | 8.05 | Prev Close | 8.05 | Low | 8.05 | High | 8.05 | Mkt Cap | 64.59M |
| Vol | 5.50M | Avg Vol | 181.96K | EPS | -2.07 | P/E | N/A | Forward P/E | -0.87 |
| Beta | 1.93 | Short Ratio | 5.31 | Inst. Own | 80.16% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | N/A | 50-d Avg | 3.04 | 200-d Avg | 3.39 | 1yr Est | 16.19 |
| Income Statement | |||
| Operating Expenses | 27.49M | ||
| Research and Development Expense | 17.41M | ||
| Selling, General and Administrative Expense | 10.08M | ||
| Operating Income | -27.49M | ||
| Net Income | -26.66M | ||
| Net Income Common Stock | -26.66M | ||
| Net Income Common Stock (USD) | -26.66M | ||
| Consolidated Income | -26.66M | ||
| Earnings per Basic Share | -0.56 | ||
| Earnings per Basic Share (USD) | -0.56 | ||
| Earnings per Diluted Share | -0.56 | ||
| Earning Before Interest & Taxes (EBIT) | -26.66M | ||
| Earning Before Interest & Taxes (USD) | -26.66M | ||
| Weighted Average Shares | 47.62M | ||
| Weighted Average Shares Diluted | 47.62M | ||
| Balance Sheet | |||
| Cash and Equivalents | 42.14M | ||
| Cash and Equivalents (USD) | 42.14M | ||
| Investments | 25.77M | ||
| Investments Current | 25.77M | ||
| Current Assets | 70.29M | ||
| Property, Plant & Equipment Net | 15.46M | ||
| Total Assets | 86.70M | ||
| Debt Current | 1.11M | ||
| Total Debt | 12.44M | ||
| Current Liabilities | 34.11M | ||
| Debt Non-Current | 11.33M | ||
| Total Liabilities | 45.44M | ||
| Accumulated Retained Earnings (Deficit) | -356.10M | ||
| Accumulated Other Comprehensive Income | 1000 | ||
| Shareholders Equity | 41.26M | ||
| Shareholders Equity (USD) | 41.26M | ||
| Assets Non-Current | 16.41M | ||
| Total Debt (USD) | 12.44M | ||
| Liabilities Non-Current | 11.33M | ||
| Trade and Non-Trade Payables | 1.55M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 496.00K | ||
| Net Cash Flow from Financing | 273.00K | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | -10.41M | ||
| Capital Expenditure | -69.00K | ||
| Issuance (Purchase) of Equity Shares | 273.00K | ||
| Net Cash Flow from Investing | 9.80M | ||
| Net Cash Flow - Investment Acquisitions and Disposals | 9.87M | ||
| Net Cash Flow from Operations | -20.48M | ||
| Share Based Compensation | 2.54M | ||